NS

Neeraj Saraswat

Active Director Director DIN 10914429
DIN 10914429 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Neeraj Saraswat

Data last updated:

Neeraj Saraswat is a Director at Alsun Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10914429
Primary Designation Director
Industry Pharma
First Appointment 21 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director21 Jan 20252025Active

Board colleagues of Neeraj Saraswat

NameDINCompanyDesignation
Gauri Shankar Sharma10914428Alsun Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Alsun Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Neeraj Saraswat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Neeraj Saraswat

Neeraj Saraswat currently holds 1 directorship: Alsun Pharmaceuticals Private Limited (Director, since 21 Jan 2025).

Neeraj Saraswat was first appointed on 21 Jan 2025 as Director at Alsun Pharmaceuticals Private Limited.

The current boards of Neeraj Saraswat's companies include Gauri Shankar Sharma (Alsun Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available